ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/02 | 1,055 | 1,069 | 1,044 | 1,063 | +13 | +1.2% | 436,300 |
| 2023/03/01 | 1,087 | 1,089 | 1,042 | 1,050 | -28 | -2.6% | 689,800 |
| 2023/02/28 | 1,068 | 1,097 | 1,068 | 1,078 | +14 | +1.3% | 586,700 |
| 2023/02/27 | 1,079 | 1,088 | 1,056 | 1,064 | -33 | -3% | 720,300 |
| 2023/02/24 | 1,115 | 1,117 | 1,093 | 1,097 | -9 | -0.8% | 288,200 |
| 2023/02/22 | 1,111 | 1,121 | 1,094 | 1,106 | -34 | -3% | 518,400 |
| 2023/02/21 | 1,155 | 1,155 | 1,130 | 1,140 | -14 | -1.2% | 326,200 |
| 2023/02/20 | 1,097 | 1,154 | 1,096 | 1,154 | +57 | +5.2% | 560,900 |
| 2023/02/17 | 1,117 | 1,140 | 1,090 | 1,097 | -31 | -2.7% | 759,500 |
| 2023/02/16 | 1,165 | 1,165 | 1,085 | 1,128 | -34 | -2.9% | 1,750,600 |
| 2023/02/15 | 1,167 | 1,169 | 1,135 | 1,162 | -11 | -0.9% | 734,300 |
| 2023/02/14 | 1,168 | 1,184 | 1,162 | 1,173 | +4 | +0.3% | 369,300 |
| 2023/02/13 | 1,166 | 1,174 | 1,147 | 1,169 | -3 | -0.3% | 324,800 |
| 2023/02/10 | 1,196 | 1,206 | 1,165 | 1,172 | -34 | -2.8% | 597,400 |
| 2023/02/09 | 1,195 | 1,208 | 1,192 | 1,206 | -3 | -0.2% | 340,500 |
| 2023/02/08 | 1,197 | 1,209 | 1,188 | 1,209 | +1 | +0.1% | 257,600 |
| 2023/02/07 | 1,208 | 1,213 | 1,198 | 1,208 | +8 | +0.7% | 229,900 |
| 2023/02/06 | 1,225 | 1,229 | 1,196 | 1,200 | -27 | -2.2% | 447,000 |
| 2023/02/03 | 1,231 | 1,243 | 1,220 | 1,227 | +9 | +0.7% | 280,800 |
| 2023/02/02 | 1,232 | 1,242 | 1,215 | 1,218 | +7 | +0.6% | 379,200 |
| 2023/02/01 | 1,202 | 1,242 | 1,197 | 1,211 | +18 | +1.5% | 415,300 |
| 2023/01/31 | 1,179 | 1,198 | 1,173 | 1,193 | -2 | -0.2% | 285,800 |
| 2023/01/30 | 1,222 | 1,233 | 1,185 | 1,195 | -20 | -1.6% | 432,800 |
| 2023/01/27 | 1,221 | 1,226 | 1,199 | 1,215 | +1 | +0.1% | 357,000 |
| 2023/01/26 | 1,238 | 1,249 | 1,210 | 1,214 | -15 | -1.2% | 319,300 |
| 2023/01/25 | 1,229 | 1,238 | 1,214 | 1,229 | -3 | -0.2% | 284,000 |
| 2023/01/24 | 1,243 | 1,246 | 1,219 | 1,232 | +8 | +0.7% | 341,400 |
| 2023/01/23 | 1,208 | 1,243 | 1,207 | 1,224 | +29 | +2.4% | 542,300 |
| 2023/01/20 | 1,213 | 1,218 | 1,182 | 1,195 | -31 | -2.5% | 517,600 |
| 2023/01/19 | 1,172 | 1,236 | 1,164 | 1,226 | +42 | +3.5% | 842,100 |
| 2023/01/18 | 1,137 | 1,197 | 1,134 | 1,184 | +54 | +4.8% | 855,400 |
| 2023/01/17 | 1,180 | 1,211 | 1,130 | 1,130 | -49 | -4.2% | 991,400 |
| 2023/01/16 | 1,199 | 1,219 | 1,175 | 1,179 | -35 | -2.9% | 680,800 |
| 2023/01/13 | 1,232 | 1,252 | 1,205 | 1,214 | -30 | -2.4% | 583,300 |
| 2023/01/12 | 1,254 | 1,261 | 1,208 | 1,244 | -9 | -0.7% | 669,900 |
| 2023/01/11 | 1,280 | 1,317 | 1,045 | 1,253 | -15 | -1.2% | 2,959,700 |
| 2023/01/10 | 1,307 | 1,319 | 1,265 | 1,268 | -29 | -2.2% | 427,000 |
| 2023/01/06 | 1,246 | 1,302 | 1,242 | 1,297 | +29 | +2.3% | 439,400 |
| 2023/01/05 | 1,288 | 1,303 | 1,266 | 1,268 | -10 | -0.8% | 514,700 |
| 2023/01/04 | 1,345 | 1,350 | 1,268 | 1,278 | -115 | -8.3% | 1,153,400 |
| 2022/12/30 | 1,351 | 1,418 | 1,324 | 1,393 | +49 | +3.6% | 1,208,600 |
| 2022/12/29 | 1,221 | 1,353 | 1,215 | 1,344 | +110 | +8.9% | 1,584,000 |
| 2022/12/28 | 1,331 | 1,331 | 1,213 | 1,234 | +23 | +1.9% | 2,261,600 |
| 2022/12/27 | 1,199 | 1,232 | 1,199 | 1,211 | +23 | +1.9% | 653,700 |
| 2022/12/26 | 1,202 | 1,213 | 1,188 | 1,188 | -13 | -1.1% | 516,800 |
| 2022/12/23 | 1,198 | 1,215 | 1,193 | 1,201 | -10 | -0.8% | 380,900 |
| 2022/12/22 | 1,231 | 1,238 | 1,198 | 1,211 | ±0 | ±0% | 539,800 |
| 2022/12/21 | 1,241 | 1,249 | 1,210 | 1,211 | -29 | -2.3% | 646,700 |
| 2022/12/20 | 1,303 | 1,309 | 1,222 | 1,240 | -75 | -5.7% | 1,119,900 |
| 2022/12/19 | 1,340 | 1,345 | 1,312 | 1,315 | -36 | -2.7% | 463,100 |
451～
500
件表示中 / 3611件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 361,000円 | +52.1% | +23.3% | - | - | - |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 450,000円 | +22.8% | +113.0% | - | - | - |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 417,000円 | +14.5% | -2.3% | - | - | - |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 333,000円 | +15.0% | -7.3% | - | - | - |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 469,500円 | +12.0% | +28.1% | - | - | - |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
